Pre-litigation Preparation and Strategy for Pharmaceutical Product Patents and Exclusivity

Market exclusivity from patents and drug approval authorities is essential for the existence of innovative drug companies. This practice note outlines preemptive steps that should be considered by in-house and outside counsel for an innovator drug company to maximize a product's regulatory and patent exclusivities and the company's chances of success in future patent litigation against generic drug applicants.